Stewart_2004_J.Med.Chem_47_2348

Reference

Title : Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning - Stewart_2004_J.Med.Chem_47_2348
Author(s) : Stewart AO , Cowart MD , Moreland RB , Latshaw SP , Matulenko MA , Bhatia PA , Wang X , Daanen JF , Nelson SL , Terranova MA , Namovic MT , Donnelly-Roberts D , Miller LN , Nakane M , Sullivan JP , Brioni JD
Ref : Journal of Medicinal Chemistry , 47 :2348 , 2004
Abstract : Stewart_2004_J.Med.Chem_47_2348
ESTHER : Stewart_2004_J.Med.Chem_47_2348
PubMedSearch : Stewart_2004_J.Med.Chem_47_2348
PubMedID: 15084133

Related information

Citations formats

Stewart AO, Cowart MD, Moreland RB, Latshaw SP, Matulenko MA, Bhatia PA, Wang X, Daanen JF, Nelson SL, Terranova MA, Namovic MT, Donnelly-Roberts D, Miller LN, Nakane M, Sullivan JP, Brioni JD (2004)
Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning
Journal of Medicinal Chemistry 47 :2348

Stewart AO, Cowart MD, Moreland RB, Latshaw SP, Matulenko MA, Bhatia PA, Wang X, Daanen JF, Nelson SL, Terranova MA, Namovic MT, Donnelly-Roberts D, Miller LN, Nakane M, Sullivan JP, Brioni JD (2004)
Journal of Medicinal Chemistry 47 :2348